The emerging paradigm of Precision Oncology 3.0 uses panomics (genomic, transcriptomic, proteomic, metabolomic, etc.) and sophisticated methods of statistical reverse engineering to hypothesise the putative networks that drive a given patient's tumour, and to attack the tumour drivers with combinations of targeted therapies. Read more
here.
No comments:
Post a Comment